- Home
- ZION vs HALO Comparison
ZION vs HALO Comparison
Compare ZION & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZION
- HALO
- Stock Information
- Founded
- ZION 1873
- HALO 1998
- Country
- ZION United States
- HALO United States
- Employees
- ZION N/A
- HALO N/A
- Industry
- ZION Major Banks
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZION Finance
- HALO Health Care
- Exchange
- ZION Nasdaq
- HALO Nasdaq
- Market Cap
- ZION 7.4B
- HALO 7.4B
- IPO Year
- ZION N/A
- HALO N/A
- Fundamental
- Price
- ZION $44.28
- HALO $58.79
- Analyst Decision
- ZION Hold
- HALO Buy
- Analyst Count
- ZION 22
- HALO 9
- Target Price
- ZION $59.24
- HALO $61.63
- AVG Volume (30 Days)
- ZION 2.6M
- HALO 1.8M
- Earning Date
- ZION 04-21-2025
- HALO 05-06-2025
- Dividend Yield
- ZION 3.89%
- HALO N/A
- EPS Growth
- ZION 13.92
- HALO 63.33
- EPS
- ZION 4.95
- HALO 3.43
- Revenue
- ZION $3,058,000,000.00
- HALO $1,015,324,000.00
- Revenue This Year
- ZION $9.81
- HALO $20.06
- Revenue Next Year
- ZION $4.71
- HALO $24.04
- P/E Ratio
- ZION $8.95
- HALO $17.14
- Revenue Growth
- ZION 2.51
- HALO 22.44
- 52 Week Low
- ZION $39.05
- HALO $37.73
- 52 Week High
- ZION $63.22
- HALO $66.00
- Technical
- Relative Strength Index (RSI)
- ZION 42.94
- HALO 44.06
- Support Level
- ZION $42.77
- HALO $57.50
- Resistance Level
- ZION $46.41
- HALO $62.14
- Average True Range (ATR)
- ZION 2.77
- HALO 2.90
- MACD
- ZION 0.02
- HALO -0.40
- Stochastic Oscillator
- ZION 44.40
- HALO 36.41
About ZION Zions Bancorporation N.A.
Zions Bancorporation is a regional us bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions primarily focuses on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.